These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 13700257)

  • 21. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental animal thrombolysis tests with direct-action fibrinolytics].
    SAILER S; EBER O
    Klin Wochenschr; 1963 Mar; 41():212-6. PubMed ID: 13976107
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardization of fibrinolytic preparations. Measurement of proteolytic and activator activity of streptokinase-activated human plasminogen.
    BAUMGARTEN W; CIMINERA JL; VAN PELT SM
    J Pharm Sci; 1962 Apr; 51():314-7. PubMed ID: 13865955
    [No Abstract]   [Full Text] [Related]  

  • 24. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
    DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA
    Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significance of fibrinolytic enzymes in surgery].
    MURAKAMI F
    Chiryo; 1962 Dec; 44():2155-65. PubMed ID: 13936693
    [No Abstract]   [Full Text] [Related]  

  • 28. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP
    Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES].
    ROSOLLECK H
    Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current possibility of thrombolytic treatment].
    VERSTRAETE M; AMERY A
    Brux Med; 1962 Dec; 42():1437-54. PubMed ID: 13996898
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE PERFORMANCE OF THROMBOLYTIC TREATMENT WITH STREPTOKINASE].
    WINCKELMANN G; HELMS M
    Med Klin; 1963 Sep; 58():1568-71. PubMed ID: 14050317
    [No Abstract]   [Full Text] [Related]  

  • 33. [Methodological research on the control of fibrinolytic therapy with streptokinase].
    CROLLE G; MARX R
    Rass Fisiopatol Clin Ter; 1962; 34():17-45. PubMed ID: 13882309
    [No Abstract]   [Full Text] [Related]  

  • 34. [ON THE ACTION OF THROMBOLYTIC DRUGS].
    PATEL J; CORMIER JM
    Mem Acad Chir (Paris); 1964 Jun; 90():628-30. PubMed ID: 14179177
    [No Abstract]   [Full Text] [Related]  

  • 35. [A contribution to fibrinolytic therapy with streptokinase and streptolysin].
    FISCHBACHER W
    Thromb Diath Haemorrh; 1961 Dec; 6():547-72. PubMed ID: 13893097
    [No Abstract]   [Full Text] [Related]  

  • 36. The activation of plasminogen by staphylokinase: comparison with streptokinase.
    DAVIDSON FM
    Biochem J; 1960 Jul; 76(1):56-61. PubMed ID: 13814337
    [No Abstract]   [Full Text] [Related]  

  • 37. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 38. The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations.
    MOSER KM; HAJJAR GC
    Am J Cardiol; 1960 Aug; 6():496-502. PubMed ID: 13773043
    [No Abstract]   [Full Text] [Related]  

  • 39. FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS.
    STEWART GT
    J Clin Pathol; 1964 May; 17(3):355-9. PubMed ID: 14159482
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombolytic therapy.
    MCNICOL GP
    Proc R Soc Med; 1963 May; 56(5):414-8. PubMed ID: 13932243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.